Regeneron Pharmaceuticals Inc (REGN)
Tarrytown, NY
Total Compensation for Fiscal Year Ending in 2024: $6,823,034
| Salary | $1,941,100 |
|---|---|
| Bonus | $0 |
| Value of Stock Awards | $0 |
| Value of Option Awards | $0 |
| Non-Equity Incentive Plan Compensation | $3,493,980 |
| Change in Pension Value and Deferred Compensation Earnings | $0 |
| All Other Compensation | $1,387,954 |
| Total | $6,823,034 |
Regeneron Pharmaceuticals Inc disclosed its CEO pay was
41
times its median employee's pay for the fiscal year ending in 2024.
How Do You Compare?
